Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Stock analysts at Roth Capital cut their Q2 2025 earnings per share estimates for shares of Celsius in a research report issued to clients and investors on Thursday, May 29th. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.17 per share for the quarter, down from their prior estimate of $0.24. The consensus estimate for Celsius’ current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius’ Q4 2025 earnings at $0.20 EPS, Q3 2026 earnings at $0.28 EPS, Q4 2026 earnings at $0.33 EPS and FY2027 earnings at $1.38 EPS.
Celsius (NASDAQ:CELH – Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). The firm had revenue of $329.28 million during the quarter, compared to analyst estimates of $349.09 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The company’s quarterly revenue was down 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.27 EPS.
Get Our Latest Stock Analysis on Celsius
Celsius Stock Up 2.8%
Shares of Celsius stock opened at $39.18 on Monday. The firm has a market cap of $10.10 billion, a price-to-earnings ratio of 89.05, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65. The business has a fifty day simple moving average of $36.48 and a 200-day simple moving average of $30.58. Celsius has a fifty-two week low of $21.10 and a fifty-two week high of $75.69.
Insiders Place Their Bets
In other Celsius news, Director Joyce Russell sold 4,000 shares of the company’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total value of $113,880.00. Following the transaction, the director now directly owns 19,106 shares of the company’s stock, valued at $543,947.82. This represents a 17.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the company’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the sale, the insider now owns 45,297 shares of the company’s stock, valued at approximately $1,167,303.69. This trade represents a 18.36% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.55% of the company’s stock.
Institutional Trading of Celsius
Several large investors have recently made changes to their positions in CELH. HM Payson & Co. boosted its stake in shares of Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after acquiring an additional 550 shares in the last quarter. Westside Investment Management Inc. bought a new stake in Celsius during the 1st quarter valued at approximately $32,000. Summit Securities Group LLC bought a new stake in Celsius during the 1st quarter valued at approximately $34,000. S.A. Mason LLC boosted its stake in Celsius by 100.0% during the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock valued at $37,000 after purchasing an additional 700 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock valued at $37,000 after purchasing an additional 750 shares during the period. Institutional investors own 60.95% of the company’s stock.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- Stock Analyst Ratings and Canadian Analyst Ratings
- Among the Market’s Most Shorted: 2 Firms With +40% Short Interest
- 10 Best Airline Stocks to Buy
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- Which Wall Street Analysts are the Most Accurate?
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.